Thoroughbred Financial Services LLC increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 6.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,714 shares of the company's stock after purchasing an additional 1,224 shares during the quarter. Thoroughbred Financial Services LLC's holdings in HCA Healthcare were worth $7,157,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Sanders Capital LLC lifted its holdings in shares of HCA Healthcare by 1.0% in the 4th quarter. Sanders Capital LLC now owns 11,655,563 shares of the company's stock valued at $3,498,417,000 after purchasing an additional 116,826 shares during the last quarter. Capital World Investors increased its stake in HCA Healthcare by 0.7% in the 4th quarter. Capital World Investors now owns 2,928,452 shares of the company's stock valued at $878,975,000 after purchasing an additional 19,121 shares in the last quarter. Northern Trust Corp increased its stake in HCA Healthcare by 12.4% in the 4th quarter. Northern Trust Corp now owns 2,017,971 shares of the company's stock valued at $605,694,000 after purchasing an additional 223,248 shares in the last quarter. Nuveen Asset Management LLC grew its holdings in HCA Healthcare by 4.5% during the 4th quarter. Nuveen Asset Management LLC now owns 1,865,771 shares of the company's stock valued at $560,011,000 after buying an additional 81,105 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of HCA Healthcare by 40,527.3% during the first quarter. GAMMA Investing LLC now owns 1,703,907 shares of the company's stock worth $5,887,850,000 after purchasing an additional 1,699,713 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.
Insider Activity at HCA Healthcare
In related news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction dated Tuesday, May 13th. The shares were sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer owned 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.30% of the company's stock.
HCA Healthcare Stock Performance
HCA traded up $2.27 during trading hours on Wednesday, hitting $366.08. The company's stock had a trading volume of 1,125,177 shares, compared to its average volume of 1,614,266. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07. The firm has a market capitalization of $85.66 billion, a PE ratio of 15.39, a PEG ratio of 1.14 and a beta of 1.39. The company has a 50-day simple moving average of $370.09 and a 200 day simple moving average of $348.16.
HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the company earned $5.50 earnings per share. The business's revenue was up 6.4% compared to the same quarter last year. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Tuesday, September 16th. HCA Healthcare's payout ratio is 12.11%.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on HCA shares. Bank of America cut HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price on the stock. in a report on Wednesday, July 16th. JPMorgan Chase & Co. boosted their target price on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Stephens upgraded shares of HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Finally, Robert W. Baird reiterated a "neutral" rating and issued a $336.00 price objective (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Nine analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $395.69.
Read Our Latest Analysis on HCA Healthcare
About HCA Healthcare
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Read More

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report